Skip to main content

Market Overview

Salesforce, Thermo Fisher Scientific, CrowdStrike And More: CNBC's 'Final Trades'

Share:
Salesforce, Thermo Fisher Scientific, CrowdStrike And More: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named the 3-Month Treasury Bill as her final trade.

Joshua Brown of Ritholtz Wealth Management named CrowdStrike Holdings, Inc. (NASDAQ: CRWD), adding that the company is scheduled to release earnings in a few days.
CrowdStrike is expected to release first-quarter results after the closing bell on May 31. Analysts expect the company to report quarterly earnings of 51 cents per share on revenue of $677.37 million.

Don’t forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners said Thermo Fisher Scientific Inc. (NYSE: TMO) is a "high quality health care company." It has been consolidating for a while. This is a good entry point, he added.

JPMorgan and Keybanc lowered their price targets on Thermo Fisher Scientific on Thursday.

Jason Snipe of Odyssey Capital Advisors named Salesforce, Inc. (NYSE: CRM), which is due to release earnings next week.

Analysts expect the company to report quarterly earnings at $1.61 per share on revenue of $8.18 billion.

Price Action: Salesforce shares gained 0.4% to settle at $209.91, while Thermo Fisher Scientific shares rose 1.9% to close at $520.64 on Thursday. CrowdStrike shares rose 0.3% to close at $149.61.

Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Industrial Stocks With Over 4% Dividend Yields

Photo via Shutterstock. 

 

Related Articles (CRM + CRWD)

View Comments and Join the Discussion!

Posted-In: Bryn Talkington CNBCLong Ideas News Top Stories Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com